| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Zhang L et al. | Effects of IL-10 and glucose on expression of OPG and RANKL in human periodontal ligament fibroblasts. | 2016 | Braz. J. Med. Biol. Res. | pmid:27074164 |
| Song DH et al. | Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis. | 2016 | Med. Sci. Monit. | pmid:27068490 |
| Kose O et al. | Influences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars. | 2016 | Mar Drugs | pmid:27043583 |
| Shah AP et al. | Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. | 2016 | PLoS ONE | pmid:27019421 |
| Dela Cruz A et al. | Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27006198 |
| Lis GJ et al. | Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. | 2016 | Pol. Arch. Med. Wewn. | pmid:27003233 |
| Li N et al. | Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. | 2016 | Pharmazie | pmid:29441931 |
| Yuan SY et al. | Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. | 2016 | Chin J Nat Med | pmid:27114313 |
| Johnson DC et al. | Genetic factors influencing the risk of multiple myeloma bone disease. | 2016 | Leukemia | pmid:26669972 |
| Davaine JM et al. | Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. | 2016 | Eur J Vasc Endovasc Surg | pmid:26652270 |
| Li J et al. | Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. | 2016 | Mol Med Rep | pmid:26647856 |
| Cervellati C et al. | Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. | 2016 | Oxid Med Cell Longev | pmid:26635910 |
| Zhao N et al. | Isolation and Functional Analysis of an Immortalized Murine Cementocyte Cell Line, IDG-CM6. | 2016 | J. Bone Miner. Res. | pmid:26274352 |
| Wang S et al. | Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats. | 2016 | J Ethnopharmacol | pmid:27109342 |
| Liu HJ et al. | Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System. | 2016 | PLoS ONE | pmid:27764190 |
| Menzel J et al. | Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. | 2016 | J. Endocrinol. Invest. | pmid:27614458 |
| O'Sullivan S et al. | Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. | 2016 | PLoS ONE | pmid:27737004 |
| Li M et al. | Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. | 2016 | J. Biol. Chem. | pmid:27697839 |
| Shirakawa J and Kulkarni RN | Novel factors modulating human β-cell proliferation. | 2016 | Diabetes Obes Metab | pmid:27615134 |
| Xing R et al. | Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. | 2016 | Int. J. Mol. Med. | pmid:27599586 |
| Yongdi L et al. | [Osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandibular distraction osteogenesis regulated by parathyroid hormone]. | 2016 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:27526445 |
| Qian H et al. | FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. | 2016 | Mol Med Rep | pmid:27510616 |
| Sun J et al. | Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. | 2016 | Int. Immunopharmacol. | pmid:27576059 |
| Sasso GR et al. | Elevated serum osteoprotegerin levels in women: friend or foe? | 2015 Nov-Dec | Rev Assoc Med Bras (1992) | pmid:26841162 |
| Calasans-Maia MD et al. | Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814461 |
| Jianru YI et al. | Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814456 |
| SaÄŸlam M et al. | Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. | 2015 Jan-Feb | J Appl Oral Sci | pmid:25760266 |
| Esteghamati A et al. | Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. | 2015 Aug-Sep | Arch Cardiovasc Dis | pmid:26184866 |
| Niu Y et al. | Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study. | 2015 | BMC Endocr Disord | pmid:26626139 |
| Miao Q et al. | Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway. | 2015 | Int J Clin Exp Pathol | pmid:26617755 |
| Goswami S and Sharma-Walia N | Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis. | 2015 | BMC Cancer | pmid:26608463 |
| Mrozikiewicz-Rakowska B et al. | Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study. | 2015 | J. Physiol. Pharmacol. | pmid:26579581 |
| Kurz K et al. | Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis. | 2015 | Dis. Markers | pmid:26576067 |
| Niu Y et al. | Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes. | 2015 | BMC Cardiovasc Disord | pmid:26260869 |
| Marley K et al. | Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL. | 2015 | Exp. Cell Res. | pmid:26254896 |
| McCarthy NI et al. | Osteoprotegerin-Mediated Homeostasis of Rank+ Thymic Epithelial Cells Does Not Limit Foxp3+ Regulatory T Cell Development. | 2015 | J. Immunol. | pmid:26254339 |
| Grosjean F et al. | Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis. | 2015 | PLoS ONE | pmid:26247358 |
| Lewis JR et al. | Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women. | 2015 | PLoS ONE | pmid:26222774 |
| Audo R et al. | Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort. | 2015 | Arthritis Res. Ther. | pmid:26220665 |
| Harrison R et al. | Acute bone response to whole body vibration in healthy pre-pubertal boys. | 2015 | J Musculoskelet Neuronal Interact | pmid:26032203 |
| Goyden J et al. | The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation. | 2015 | PLoS ONE | pmid:26030441 |
| Beederman M et al. | Osteoprotegerin deficiency results in disruption of posterofrontal suture closure in mice: implications in nonsyndromic craniosynostosis. | 2015 | Plast. Reconstr. Surg. | pmid:26017615 |
| Tanaka Y et al. | [Mesenchymal stem cells for the treatment and repair of inflammatory arthritis]. | 2015 | Nihon Rinsho Meneki Gakkai Kaishi | pmid:26016635 |
| Priyadarshi S et al. | Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients. | 2015 | Ann. Hum. Genet. | pmid:25998045 |
| Han J et al. | [Determination of bone metabolic marker levels in perio-implant crevicular fluid and analysis of dental implants stability by resonance frequency in the early stage of healing]. | 2015 | Beijing Da Xue Xue Bao | pmid:25686326 |
| Yang X et al. | Effects of TGF-β1 on OPG/RANKL expression of cementoblasts and osteoblasts are similar without stress but different with mechanical compressive stress. | 2015 | ScientificWorldJournal | pmid:25685846 |
| Chung CP et al. | A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study. | 2015 | Int J Mol Sci | pmid:25679449 |
| HaDuong JH et al. | Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis. | 2015 | Int. J. Cancer | pmid:25648303 |
| Higgs JT et al. | Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. | 2015 | Mol. Cancer Res. | pmid:25636966 |
| Maser RE et al. | Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 Diabetes. | 2015 | Endocr Pract | pmid:25100392 |